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ongoing randomized clinical trials on the 
effects of VDR activation on renal failure-
induced cardiac mortality and the progres-
sion of albuminuria (PRIMO and VITAL) 
seem highly warranted, and we are awaiting 
the results. The present results of Freund-
lich et al.9 show that the expanding targets 
of VDR activation include downregulation 
of multiple RAS components.
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Regulation of the Na+-Cl– 
cotransporter by dietary NaCl:  
a role for WNKs, SPAK, OSR1,  
and aldosterone
Volker Vallon1,2,3
This Commentary aims to integrate or interrelate the available data with 
the current study by Chiga and co-workers, which defines an important 
influence of aldosterone in the phosphorylation and thus activation of 
the Na+-Cl– cotransporter (NCC) in response to changes in NaCl intake 
and implicates the involvement of SPAK/OSR1 kinases and WNKs.
Kidney International (2008) 74, 1373–1375. doi:10.1038/ki.2008.477
An impaired ability of the kidney to 
excrete NaCl plays a critical pathophysi-
ological role for a long-term increase in 
blood pressure. The aldosterone-sensi-
tive distal nephron is of primary impor-
tance in the regulation of renal NaCl 
excretion and thus body NaCl home-
ostasis. The stimulatory effect of aldos-
terone on the epithelial sodium channel 
(ENaC) is well known and primarily 
localized to the late distal convoluted 
tubule (DCT) and connecting tubule. 
Less appreciated is the regulation of the 
Na+-Cl– cotransporter (NCC) in the 
DCT by aldosterone and other regula-
tors. Moreover, whereas much has been 
learned about the molecular pathways 
involved in the regulation of ENaC, 
still relatively little is known about the 
determinants of NCC activity. The study 
by Chiga and co-workers1 (this issue) 
provides new in vivo evidence in this 
regard, as they indicate an important 
role of aldosterone in the regulation of 
NCC phosphorylation by dietary salt 
intake. Moreover, evidence is provided 
that the signaling cascade involves with-
no-lysine kinase (WNK) and the mam-
malian STE20 (sterile 20)-like kinases 
SPAK (STE20/SPS1-related proline/
alanine-rich kinase) and OSR1 (oxida-
tive stress-responsive kinase-1).
SPAK and OSR1 were discovered 
through their ability to interact with, 
phosphorylate, and stimulate the activ-
ity of the Na+-K+-2Cl– cotransporter 
(NKCC1), a member of a superfamily of 
electroneutral cation-coupled chloride 
cotransporters (SLC12) (reviewed by 
Delpire and Gagnon2). The Na+-driven 
members of this superfamily include 
NKCC1 and NKCC2, as well as NCC. 
Fragments of these cotransporters con-
taining a cluster of conserved threonine 
residues are phosphorylated in vitro by 
the SPAK/OSR1 kinases. The SPAK and 
OSR1 enzymes themselves are phospho-
rylated and activated by the WNK1 and 
WNK4 protein kinases (reviewed by 
Delpire and Gagnon2). These findings 
suggest that a signaling cascade includ-
ing WNK1, WNK4, and SPAK/OSR1 
could be involved in the regulation of 
the Na+-driven members of the SLC12 
superfamily, including NCC.
WNK1 and WNK4 are mutated in 
patients with pseudohypoaldosteronism 
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type II (PHAII), an autosomal-dominant 
disorder characterized by hyperkalemia 
and hypertension (reviewed by Kahle et 
al.3). Importantly, patients with PHAII 
are rather sensitive to pharmacological 
inhibition of NCC by thiazide diuret-
ics. Moreover, transgenic mice or gene 
knock-in mice carrying the PHAII muta-
tion on the Wnk4 gene have their PHAII 
phenotypes corrected when treated 
with thiazides or when crossed with 
mice lacking NCC. These studies indi-
cated that NCC is a primary effector of 
WNK4 mutations in the pathogenesis of 
PHAII. Overactivation of NCC in PHAII 
enhances NaCl reabsorption in the DCT 
and impairs the ability of the kidney to 
excrete NaCl and thus increases blood 
pressure. Enhanced NCC-mediated 
reabsorption of Na+ in the DCT limits 
the Na+ available for Na+/K+ exchange 
in the distal nephron, thereby impairing 
renal ability to excrete K+. Mutations in 
WNK1 and WNK4 may in addition affect 
other renal transport systems that can 
contribute to the PHAII phenotype.3
Importantly, the enhanced phospho-
rylation and activation of NCC in Wnk4 
PHAII knock-in mice were associated 
with enhanced phosphorylation of SPAK/
OSR1 kinases,4 implicating a potential 
role of WNK/SPAK/OSR1 kinases in 
NCC phosphorylation and activation 
in the PHAII phenotype. In accordance, 
more recent studies demonstrated that 
SPAK and OSR1 kinases phosphorylate 
human NCC at three conserved residues 
(Thr46, Thr55, and Thr60).5 Moreo-
ver, activation of the WNK1–SPAK/
OSR1 signaling pathway by treatment 
of HEK293 or mpkDCT-derived cells 
with hypotonic low-chloride conditions 
induced phosphorylation of NCC at 
the residues phosphorylated by SPAK/
OSR1 kinases. Efficient phospho rylation 
of NCC required docking interactions 
between NCC and SPAK/OSR1. Finally, 
mutation of Thr60 in NCC markedly 
inhibited phosphorylation of Thr46 
and Thr55, as well as NCC activation 
in response to hypotonic low-chloride 
treatment of HEK293 cells. These stud-
ies implicated the WNK1–SPAK/OSR1 
signaling pathway in the phosphorylation 
and activation of human NCC.5
The current study by Chiga and 
co-workers1 elucidated the potential 
physiological relevance of WNK4 and 
SPAK/OSR1 in the regulation of NCC 
by dietary salt. They showed that in 
wild-type mice the phosphorylation 
status of SPAK and OSR1, as well as 
of NCC (at Ser71, Thr53, and Thr58), 
is inversely related to NaCl intake, and 
immunofluorescence evidence was 
provided that most of the expression of 
phosphorylated SPAK/OSR1  was con-
fined to the NCC-expressing nephron 
segments. Moreover, and intriguingly, 
application of aldosterone to wild-
type mice on a high-salt diet increased 
phosphorylation of SPAK/OSR1 as 
well as NCC. Vice versa, blocking of 
aldosterone receptors by spironolac-
tone in wild-type mice fed a low-salt 
diet decreased the phosphorylation sta-
tus.1 Previous studies have shown that 
mutations of rat NCC Thr53, Thr58, 
and Ser71 completely reduce NCC acti-
vation in oocytes following hypotonic 
low-chloride treatment.6 Moreover, 
Thr55 and Thr60 in human NCC cor-
respond to Thr53 and Thr58 in mouse 
NCC. Thus, a low-salt diet or exogenous 
aldosterone in mice as well as exposure 
of DCT-derived cells to a hypotonic 
low-chloride medium phosphorylates 
NCC at residues that correspond to the 
human NCC residues phosphorylated 
by SPAK/OSR1. Together, these studies 
provide very strong evidence for a role 
of SPAK/OSR1 in the phosphorylation 
and activation of NCC in response to a 
low-NaCl diet and aldosterone.
What do we know about the regula-
tion of WNK1 and WNK4 in the kidney 
and their effects on NCC? In the kidney, 
a 5′-truncated kinase-deficient WNK1-
short isoform (WNK1-S) predomi-
nates, whereas full-length WNK1-long 
(WNK1-L) is ubiquitously expressed at 
low levels. Moreover, mRNA expression 
of WNK1-S and WNK4 is strongest in 
the DCT and connecting tubule and 
drops sharply in the collecting duct;7 
that is, the expression is highest in 
the segments expressing NCC and the 
greatest activity of ENaC. WNK4 is, in 
addition, expressed in the thick ascend-
ing limb and the macula densa. Impor-
tantly, a high K+ intake upregulated 
WNK1-S and WNK4, and low intake 
of K+ or NaCl reduced WNK1-S in 
mouse kidney.7 Notably, the responses 
Figure 1 | Model for the activation of NCC by increasing membrane expression and 
phosphorylation in the distal convoluted tubule (DCT). Effects are stimulatory (green arrows) or 
inhibitory (red breaks). In addition, a cell of the late DCT (DCT2)/connecting tubule (CNT) is shown 
to illustrate the indirect effect of inhibition of NCC-mediated Na+ reabsorption by high K+ intake on 
ROMK- and BK channel–mediated K+ excretion. Ang II, angiotensin II.
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to changes in K+ intake were much 
more pronounced than the responses 
to changes in NaCl intake. This stresses 
the importance of the system for K+ 
balance. It also indicates that potential 
secondary effects on K+ homeostasis 
have to be considered when effects of 
a given maneuver on changes in WNK 
expression are studied (including the 
responses to exogenous aldosterone 
or spironolactone). Expression stud-
ies in Xenopus oocytes suggested that 
WNK4 inhibits NCC-mediated NaCl 
reabsorption by reducing NCC mem-
brane expression, and WNK1-L may 
in turn attenuate WNK4 (reviewed by 
Kahle et al.3 and McCormick et al.8). 
Kinase-deficient WNK1-S was proposed 
to attenuate the inhibitory influence of 
WNK1-L on WNK4, thereby increas-
ing NCC expression in the membrane. 
WNKs are active kinases as well as scaf-
folds that can have unexpected effects 
when expressed at high levels. As a 
consequence, caution is needed in the 
interpretation of studies with overex-
pression. Nevertheless, the outlined 
findings could be integrated as follows 
(Figure 1): Low NaCl intake inhibits the 
expression of WNK1-S, thereby dis-
inhibiting WNK1−L. The latter, through 
effects on WNK4, stimulates NCC 
membrane expression, whereas WNK1-
L−mediated phosphorylation of SPAK/
OSR1 phosphorylates and activates 
NCC. Both will help to increase NCC 
activity and conserve NaCl. In compari-
son, a high-K+ diet increases WNK1-S 
and WNK4 expression. WNK1-S 
inhibits WNK1-L, thereby inhibiting 
the membrane expression of NCC by 
disinhibition of WNK4. In addition, 
lowering WNK1-L reduces SPAK/
OSR1-mediated phosphorylation and 
activation of NCC. Both changes will 
reduce NCC activity and thus enhance 
the Na+ delivery for Na+/K+ exchange 
via ENaC, ROMK channel, and the BK 
channel and increase K+ excretion. Pre-
liminary data in mice show that phos-
phorylation of NCC Ser71 is inversely 
related to dietary K+ intake (V.V. et al., 
unpublished observations).
Both WNK1-L and WNK4 can phos-
phorylate SPAK/OSR1 in vitro.2 WNK1-
L-induced phosphorylation of SPAK/
OSR1 and activation of NCC fits with 
the outlined physiological scenarios. 
WNK4-mediated phosphorylation and 
activation of SPAK/OSR1/NCC could be 
conflicting with the observed increase in 
WNK4 expression and proposed inhibi-
tion of NCC activity in response to high 
K+ intake (Figure 1). The current study 
by Chiga and co-workers1 reports that 
the increased phosphorylation of SPAK/
OSR1/NCC in Wnk4 PHAII knock-in 
mice was unresponsive to changes in 
NaCl intake, suggesting a role of Wnk4 
in the phosphorylation of SPAK/OSR1. 
One may speculate that the Wnk4 
PHAII mutant itself phosphorylates 
NCC or that the mutant enhances 
WNK1-L activity. In addition or alter-
natively, the Wnk4 PHAII mutant may 
disinhibit WNK3, another member of 
the WNK family that more recently has 
been found to stimulate NCC activity 
and to interact with WNK4 and WNK-
-S in vitro (reviewed by McCormick et 
al.8) (Figure 1). The physiological rel-
evance of WNK3 and its role in OSR1/
SPAK/NCC signaling remain to be 
determined.
Aldosterone levels increase in response 
to low NaCl and high K+ intake. The 
opposing effects of these diets on NCC 
phosphorylation and activity implicate 
additional regulators (Figure 1). WNK4 
has been reported to be phosphorylated 
by the serum- and glucocorticoid-
regulated kinase-1 (SGK1),9 which is 
expressed and activated in response to 
aldosterone. Notably, SGK1 phosphor-
ylation of WNK4 alleviates the inhibi-
tory effects of WNK4 on ENaC3 and 
possibly on NCC (Figure 1). Whether 
SGK1 phosphorylation of WNK4 affects 
phosphorylation of OSR1/SPAK/NCC 
or the membrane expression of NCC 
remains to be determined. Mice lacking 
Sgk1 have an impaired renal ability to 
conserve NaCl and excrete K+.10 Prelim-
inary data indicate that phosphorylation 
of NCC Ser71 in response to a low-NaCl 
diet is attenuated in mice lacking Sgk1; 
in comparison, a high-K+ diet induced 
hyperkalemia in these mice, associ-
ated with an exaggerated suppression 
of NCC Ser71 phosphorylation, which 
may serve to deliver more Na+ to the 
distal segments of impaired Na+/K+ 
exchange in the absence of Sgk1 (V.V. et 
al., unpublished observations).
In summary, NCC in the distal con-
voluted tubule plays a critical role in 
NaCl and, indirectly, in K+ homeosta-
sis. Recent studies implicated its regu-
lation by WNK kinases. The current in 
vivo study by Chiga and co-workers1 
has defined an important influence of 
aldosterone in the phosphorylation 
and activation of NCC in response to 
changes in NaCl intake, and implicates 
the involvement of SPAK/OSR1 kinases 
and WNKs.
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